Lindsay Hollander
Overview
Explore the profile of Lindsay Hollander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo X, Jessel S, Qu R, Kluger Y, Chen T, Hollander L, et al.
Eur J Cancer
. 2022 Feb;
165:81-96.
PMID: 35219026
Background: Although programmed cell death protein 1 (PD-1) inhibitors have revolutionised treatment for advanced melanoma, not all patients respond. We previously showed that inhibition of the flavoprotein renalase (RNLS) in...
2.
Wang Y, Safirstein R, Velazquez H, Guo X, Hollander L, Chang J, et al.
J Cell Mol Med
. 2017 Feb;
21(7):1260-1265.
PMID: 28238213
Renalase was discovered as a protein synthesized by the kidney and secreted in blood where it circulates at a concentration of approximately 3-5 μg/ml. Initial reports suggested that it functioned...
3.
Hollander L, Guo X, Velazquez H, Chang J, Safirstein R, Kluger H, et al.
Cancer Res
. 2016 May;
76(13):3884-94.
PMID: 27197188
To sustain their proliferation, cancer cells overcome negative-acting signals that restrain their growth and promote senescence and cell death. Renalase (RNLS) is a secreted flavoprotein that functions as a survival...
4.
Guo X, Hollander L, MacPherson D, Wang L, Velazquez H, Chang J, et al.
Sci Rep
. 2016 Mar;
6:22996.
PMID: 26972355
An essential feature of cancer is dysregulation of cell senescence and death. Renalase, a recently discovered secreted flavoprotein, provides cytoprotection against ischemic and toxic cellular injury by signaling through the...
5.
Jimenez R, Hollander L, Boyd T
Conn Med
. 2016 Feb;
80(1):29-35.
PMID: 26882789
Unlabelled: Accelerated partial breast irradiation via brachytherapy (APBI-b) is offered as an alternative to whole breast irradiation (WBI) for selected patients with breast cancer. This study evaluates our clinical experience...